Lizzi 500 Tablet contains Azithromycin 500 mg, a macrolide antibiotic effective against a broad spectrum of bacterial infections. It functions by inhibiting bacterial protein synthesis, thereby preventing the growth and multiplication of susceptible bacteria. Lizzi 500 is commonly prescribed for the treatment of respiratory tract infections such as community-acquired pneumonia, bronchitis, and sinusitis, as well as skin and soft tissue infections, sexually transmitted infections including chlamydia, and certain ear infections like otitis media. The drug exhibits a prolonged half-life, allowing for convenient once-daily dosing and shorter treatment courses compared to other antibiotics. It is generally well tolerated; however, potential adverse effects may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. Hypersensitivity reactions, although rare, may occur and warrant immediate medical attention. Caution is advised in patients with hepatic impairment or a history of cardiac arrhythmias due to the risk of QT interval prolongation. Lizzi 500 should be used strictly under medical supervision, with adherence to prescribed dosage and duration to minimize the risk of antibiotic resistance. It is contraindicated in individuals with known hypersensitivity to azithromycin or other macrolides. This medication should not be used for viral infections such as the common cold or flu.